| COOPER COMPANIES |
| USA |
| Gesundheit |
| US2166485019 / A402VX |
| CP60 (Frankfurt) / COO (NASDAQ) |
| FRA:CP60, ETR:CP60, CP60:GR, NASDAQ:COO |
| - |
| https://www.coopercos.com.. |
|
The Cooper Companies, Inc. is a global medical device company operating through two primary segments: CooperVision and CooperSurgical. CooperVision specializes in vision care, offering a comprehensive portfolio of contact lenses including spherical, ..
>Volltext.. |
| 11692.71 Mio. EUR |
| 13679.21 Mio. EUR |
| 3589.85 Mio. EUR |
| 947.29 Mio. EUR |
| 347.06 Mio. EUR |
| 1.75 EUR |
| 2161.31 Mio. EUR |
| 108.08 Mio. EUR |
| 749.11 Mio. EUR |
| 0.08 |
| -7.61% |
| -15.53% |
| - |
| - |
| - |
| 26.07.23 - 0.00160875€ 20.01.23 - 0.00160875€ >weitere anzeigen... |
| - |
| COOPER COMPANIES, COOPERCOMPANIES, COOPER COS |
| 01.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|